The BCMA IHC assay has been validated on FFPE tissue blocks, including decalcified bone marrow core biopsies as a single stain and as a dual stain with other biomarkers such as CD138. Multiple BCMA flow cytometry assays have been validated on bone marrow aspirate, alone or as part of a broader multiple myeloma minimal residual disease panel.
Hematogenix, 708-444-0444
Pages: 1 2